We would like to highlight Digirad Corp. (NASDAQ: DRAD). The company is a provider of cardiovascular imaging services and solid-state nuclear medicine imaging products to physician offices, hospitals and other medical services. The Company has designed and commercialized the solid-state nuclear gamma camera for the detection of cardiovascular disease and other medical conditions.
In the company’s news Friday,
Digirad Corporation (NASDAQ: DRAD) announced the beginning of trials on a new medical imaging system, which will use proprietary technology to correct image distortion. The company says its new Cardius X-ACT system is expected to be available for sale in mid-2009, pending required regulatory approvals.
Attenuation, or image correction, is a common issue in myocardial perfusion imaging, also known as cardiac imaging based on SPECT (single photon emission computed tomography). The process to capture images includes injection of small amounts of radioactive substances, which can then be tracked.
Solutions to lessening attenuation already exist, said Richard Conwell, senior vice president of technology, “but they involve tradeoffs, such as “noisy” images, truncated scans, lengthy procedures with risk of excess movement by patients, or higher levels of radiation dosage.”
SPECT images are used to identify blockages in coronary arteries, evaluate risk of a heart attack, and assess a patient’s condition after major heart surgery. “We are seeing improvement in imaging clarity and accuracy, more rapid imaging, and a significant reduction in radiation dosage,” said Digirad CEO Mark Casner.
The new system, Cardius X-ACT, will be exhibited at the 2008 Annual Scientific Session of the American Society of Nuclear Cardiology, Sept 10-14, at the John B. Hynes Convention Center in Boston.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.
To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
